Informações:
Falhas:
ID
18933
Descrição
Study of CEP-701 in Treatment of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00081601
Link
https://clinicaltrials.gov/show/NCT00081601
Palavras-chave
Versões (1)
- 25/11/2016 25/11/2016 -
Transferido a
25 de novembro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Prostate Cancer NCT00081601
Eligibility Prostate Cancer NCT00081601
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00081601
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
at least 18 yrs of age
boolean
C0001779 (UMLS CUI [1])
Adenocarcinoma of prostate
Item
diagnosis of adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Neoplasm Metastasis Detectable | Radioisotope scan of bone | X-Ray Computed Tomography
Item
no detectable metastatic disease as assessed by bone and ct scans
boolean
C0027627 (UMLS CUI [1,1])
C3830527 (UMLS CUI [1,2])
C0203668 (UMLS CUI [2])
C0040405 (UMLS CUI [3])
C3830527 (UMLS CUI [1,2])
C0203668 (UMLS CUI [2])
C0040405 (UMLS CUI [3])
Serum Prostate Specific Antigen Increased
Item
has increasing serum psa concentrations
boolean
C1883014 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of at least 3 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
ecog of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Antiandrogen therapy Withdrawn
Item
has been withdrawn from antiandrogen therapy for at least 6 weeks prior to entering screening period
boolean
C0279492 (UMLS CUI [1,1])
C0424092 (UMLS CUI [1,2])
C0424092 (UMLS CUI [1,2])
Asymptomatic Disease
Item
has asymptomatic disease
boolean
C2936329 (UMLS CUI [1])
Gastrointestinal ulcer | Gastrointestinal Hemorrhage
Item
has active gi ulceration or bleeding
boolean
C0237938 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
C0017181 (UMLS CUI [2])
cancer treatment Systemic Hormonal | Therapeutic radiology procedure
Item
has been treated with non-hormonal systemic anticancer therapy or has received radiation within 4 weeks of baseline visit
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0458083 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2])
C0205373 (UMLS CUI [1,2])
C0458083 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2])
Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Creatinine measurement, serum
Item
bilirubin >2x uln or alt or ast >2xuln or serum creatinine >1.5mg/dl
boolean
C1278039 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
Hemoglobin | Platelet Count measurement | Absolute neutrophil count
Item
hemoglobin <9g/dl or platelets below 100,000/ul or anc below 1500/ul
boolean
C0019046 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
HIV Protease Inhibitors
Item
receiving treatment for hiv with protease inhibitors
boolean
C0162714 (UMLS CUI [1])
Malignant Neoplasms | Basal cell carcinoma Resected | Squamous cell carcinoma of skin Resected
Item
has had prior malignancy within past 5 yrs with exception of resected basal or squamous cell carcinomas of the skin
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1521996 (UMLS CUI [2,2])
C0553723 (UMLS CUI [3,1])
C1521996 (UMLS CUI [3,2])
C0007117 (UMLS CUI [2,1])
C1521996 (UMLS CUI [2,2])
C0553723 (UMLS CUI [3,1])
C1521996 (UMLS CUI [3,2])
Investigational New Drugs
Item
has used investigational drug with previous one month
boolean
C0013230 (UMLS CUI [1])